GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GN10337 structure
    GN10337Tyrosol
    CAS: 501-94-0
    Purity: >99.00%
  • GN10342 structure
    GN10342Chondroitin sulfate (from bovine)
    CAS: 9007-28-7
    Purity: >95.00%

    يعتبر الكوندرويتين سلفات، واحدًا من خمس فئات من الجلايكوزامينوغليكانات، قد استخدم على نطاق واسع في علاج التهاب المفاصل التنكسية.

  • GN10348 structure
    GN10348Proanthocyanidin B1
    CAS: 20315-25-7
    Purity: >98.00%
  • GN10356 structure
    GN10356Calycosin-7-glucoside
    CAS: 20633-67-4
    Purity: >99.50%
  • GN10357 structure
    GN10357Parthenolide
    CAS: 20554-84-1
    Purity: >98.00%

    Parthenolide is an NF-κB inhibitor with IC 50 values for Eca109, KYSE-510, SiHa and MCF-7 cells of approximately 10.3, 13.3, 8.42 and 9.54µM at 48h respectively.

  • GN10358 structure
    GN10358Berbamine hydrochloride
    CAS: 6078-17-7
    Purity: >98%
  • GN10368 structure
    GN10368Schisantherin A
    CAS: 58546-56-8
    Purity: >98.00%
  • GN10370 structure
    GN10370Luteolin
    CAS: 491-70-3
    Purity: >98.00%

    Luteolin is a flavonoid compound with multiple functions such as anti-inflammatory, antioxidant, and anti-cancer. Luteolin is an effective inhibitor of nuclear factor erythroid 2-related factor 2 (Nrf2).

  • GN10388 structure
    GN10388Gallic acid
    CAS: 149-91-7
    Purity: >99.00%

    Gallic acid is a 3,4,5-trihydroxybenzoic acid phenolic compound with antioxidant, anti-inflammatory and antitumor activities.

  • GN10395 structure
    GN10395Prim-O-glucosylcimifugin
    CAS: 80681-45-4
    Purity: >98.00%
  • GN10409 structure
    GN10409cor-nuside
    CAS: 131189-57-6
    Purity: >98.50%
  • GN10415 structure
    GN10415Astilbin
    CAS: 29838-67-3
    Purity: >97.00%
  • GN10422 structure
    GN10422Echinacoside
    CAS: 82854-37-3
    Purity: >98.00%

    Echinacoside is a phenylethanoid glycoside isolated from Cistanche tubulosa with potent antioxidant and anti-inflammatory effects.

  • GN10423 structure
    GN10423Lipoic acid
    CAS: 62-46-4
    Purity: >99.50%
  • GN10429 structure
    GN10429Neochlorogenic acid
    CAS: 906-33-2
    Purity: >98.00%
  • GN10436 structure
    GN10436Morusin
    CAS: 62596-29-6
    Purity: >98.50%

    Morusin فلين فلافون مزوَّد بمجموعة برنيل ملحوظ في Morus alba ( Moraceae )جذر القشرة، الذي يظهر نشاط مضاد للورم في العلاج لسرطان البروستاتا.

  • GN10442 structure
    GN10442Curculigoside
    CAS: 85643-19-2
    Purity: >99.50%
  • GN10443 structure
    GN10443Berbamine
    CAS: 478-61-5
    Purity: >98.00%
  • GN10448 structure
    GN10448Lycopene
    CAS: 502-65-8
    Purity: >90.00%

    Lycopene is a fat-soluble carotenoid molecule that is found in high concentrations in red fruits and vegetables and has a strong antioxidant effect.

  • GN10450 structure
    GN10450Ginsenoside F3
    CAS: 62025-50-7
    Purity: >99.50%
  • GN10475 structure
    GN10475Rhein
    CAS: 478-43-3
    Purity: >98.00%
  • GN10484 structure
    GN10484Amentoflavone
    CAS: 1617-53-4
    Purity: >98.00%

    Amentoflavone is an orally active phenolic compound with anti-inflammatory, anti-oxidation, anti-microbial, and anti-cancer activities.

  • GN10491 structure
    GN10491Mangiferin
    CAS: 4773-96-0
    Purity: >99.50%
  • GN10503 structure
    GN10503Piceatannol
    CAS: 10083-24-6
    Purity: >98.00%

    Piceatannol (3,3′,4,5′-trans-trihydroxystilbene) is a naturally occurring hydroxylated analogue of resveratrol.